Yatsen has participated in a series A-plus round for the diversified drug developer, six months after its closed a $60m series A.

Earthshot Ventures, a venture capital spinoff of Elemental Excelerator, counts the software provider among its limited partners.

Liberty Global helped the MathCapital and Here-backed customer intelligence software provider take its series C funding to $71.5m.

MassMutual Ventures and Advance Venture Partners returned to back the relationship management tool provider’s latest round, which brought its overall funding to $120m.

Eli Lilly and Alexandria Real Estate Equities are among the investors in a round that took the protein drug developer’s total funding to over $150m.

HomeLane has now taken in over $104m of funding since it was founded, including a series E round backed by Pidilite Group.

Palantir and Leonardo have helped solar-powered aircraft technology developer Skydweller fill out its oversubscribed series A funding round.

Myeg returned for augmented reality technology developer HiScene's $41.6m series C-plus round while celiac disease drug developer Calypso Biotech hiked a corporate-backed round to over $33m.

Based on technology at University of Pennsylvania, iEcure has launched to commercialise gene therapies initially for liver disorders and an option to license more assets.

Illumina’s corporate venturing unit took part in a round that brought the proteomic platform developer’s overall funding to $110m.